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Abstract: By exploiting the regioselective protection of the hydroxyl groups of silibinin along with
the well-known phosphoramidite chemistry, we have developed an efficient strategy for the synthesis
of new silibinin-modified species, which we have named Phosphate-Linked Silibinin Dimers (PLSd),
in which the monomer units are linked by phosphodiester bonds. The antioxidant abilities of the new
PLSd were estimated on HepG2 cells using DPPH free radical scavenging and xanthine/xanthine
oxidase assays. The new phosphate-metabolites showed a higher anti-oxidant activity than the
silibinin, as well as very low toxicity. The ability to scavenge reactive oxygen species (ROS) such as
singlet oxygen (1O2) and hydroxyl radical (HO
•) reveals that the two dimers are able to scavenge
HO• about two times more effectively than silibinin. Finally, solubility studies have shown that the
PLSd present good water solubility (more than 20 mg·L−1) under circumneutral pH values, whereas
the silibinin was found to be very poorly soluble (less than 0.4 mg·L−1) and not stable under alkaline
conditions. Together, the above promising results warrant further investigation of the future potential
of the PLSd as anti-oxidant metabolites within the large synthetic polyphenols field.
Keywords: silibinin; phosphodiester; oligoflavonoids; xanthine/xanthine oxidase assay; radical
scavengers; reactive oxygen species (ROS)
1. Introduction
Polyphenols are widely distributed in Nature and in many cases are the active compounds of the
medicinal plants from which they can be isolated. Despite their few and common biosynthetic origins,
polyphenols encompass many subclasses of structurally diverse entities from different pharmacological
properties. Most of them are small molecules bearing a few hydroxyphenyl units, but many others
consist of more complex oligomeric polyphenols with interesting pharmacological properties. The high
structural diversity of these oligomers, attributed to regio- and stereochemical variations of their
inter-linkages, makes their purification from natural extracts very laborious. For the same reasons,
the design and chemical synthesis of these oligomers is a difficult challenge. Many studies suggest that
the mechanisms by which plant polyphenols exert their protective actions against cardiovascular and
neurodegenerative diseases, as well as cancer and diabetes, are due to their reactive oxygen species
(ROS) scavenging activities as well as their ability to directly bind to biotargets such as peptides,
proteins and nucleic acids [1]. The acclaimed capability of polyphenols to scavenge reactive oxygen
species (ROS) is frequently cited to be the key property underlying the prevention and/or reduction of
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oxidative stress-related chronic diseases and age-related disorders such as cardiovascular diseases,
carcinogenesis, and neurodegeneration [2–5]. Silibinin (1, Figure 1), a flavonolignan derived from
the combination of a phenylpropanoid (taxifolin) and coniferyl alcohol, belongs to this large group
of polyphenols [6]. Silibinin is the most abundant component of silymarin, the extract matrix of the
milk thistle seeds (Silybum marianum (L.) Gaertn.) [7]. The silymarin extract contains a variety of the
flavonolignans as indicated in Figure 1.
In the past two decades, the silibinin has received much attention [8] due to its anticancer
and chemopreventive actions, as well as its hypocholesterolemic [9], cardioprotective and
neuroprotective [10–12] activities. Silibinin is a diastereoisomeric mixture of two flavonolignans,
namely silybin A and silybin B, at a ratio of approximately 1:1. In vivo applications of silibinin are
however hampered by its very low bioavailability and water solubility.
Figure 1. Structures of all components of silymarin.
The synthesis of 3,9′ ′-O-bis-hemisuccinate silibinin, was the first example of a water-soluble
analogue that enabled an intravenous application of silibinin (Legalon-SIL, Madaus, Germany) for the
treatment of acute liver intoxication by mycotoxins. In an attempt to improve its biological properties
and facilitate in vivo applications, a variety of structural modifications have been proposed, however,
new modifications are still few in number [8]. Therefore, new synthetic approaches for selectively
modifying silibinin are of high interest.
Natural products, including flavonolignans, terpenes and lignans are the focus of our latest
research [13–17] and in this framework the synthesis of new 9′ ′-phosphodiester conjugated silibinin
derivatives is noteworthy [18–20]. The insertion of a suitable label and a phosphate group increases
the water solubility of the silibinin aglycon and promotes a pro-drug approach making it possible to
improve its pharmaceutical, pharmacokinetic and/or pharmacodynamic properties.
As a part of our continuing research effort on the synthesis of new natural product analogues
by exploiting phosphoramidite chemistry [21–24] and inspired by oligoflavonoid structures [1], here,
we present an efficient synthesis of some new silibinin derivatives, the Phosphate-Linked Silibinin
dimers (PLSd) and related studies of their redox behaviour. In particular, exploiting the selective
protection of the hydroxyl groups of the silibinin, we have developed an efficient strategy for the
synthesis in good yields of new 3-3, 3-9′ ′ and 9′ ′-9′ ′ silibinin dimers (Scheme 1).
Preliminary experiments were carried out to evaluate some properties by different approaches
(radical scavenger behaviour and oxidative stress protection) and compare them to those of the
parent silibinin. For use in a pro-drug approach, the serum stability of the new dimers was
determined by HPLC analyses, and their anti-oxidant behaviours were evaluated on HepG2 cells by
the xanthine/xanthine oxidase (X/XO) assay. The water solubility, the radical scavenger efficiency
(DPPH test) and the ability to react with reactive oxygen species (ROS) of silibinin and the dimers were
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also determined. Reactivity with ROS was quantified by estimating their second order rate constant
with singlet oxygen (1O2) and hydroxyl radical (HO
•) in solution. For this purpose, 545 nm centered
excitation of Rose Bengal (RB) and laser flash photolysis experiments were coupled with a kinetic
competition approach.
Scheme 1. Retrosynthetic scheme of Phosphate-Linked Silibinin dimers.
2. Results and Discussion
2.1. Synthesis of Phosphate-Linked Silibinin Dimers
Silibinin is a flavonolignan with five hydroxyl groups (three phenolic, one secondary
and one primary) with different reactivity. To obtain suitable building blocks 2 and 3,
we developed regioselective reactions using different amounts of isobutyryl chloride in THF to
0 ◦C (Scheme 2). After 30 min, the reactions were stopped by quenching with a few drops of
H2O and after silica gel chromatography, the desired compounds 2 and 3 were obtained in 15%
and 28% yields, respectively. To prepare the corresponding phosphoramidites, we converted
compounds 2 and 3 (Scheme 2) into the phosphoramidites 4 and 5 by the classic reaction with
2-cyanoethyl-N,N-diisopropylamino-chlorophosphoramidite.
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Scheme 2. Synthesis of silibinin building blocks. Reagents and conditions: (a) isobutyryl chloride, DIEA,
THF 0 ◦C; (b) 2-cyanoethyl-N,N-diisopropylaminochlorophosphoramidite, DIEA, DCM, rt.
After appropriate work-up, silica gel chromatography afforded the desired compounds 4 and
5 at 65% yields. The identities of compounds 2–5 were confirmed by NMR (1H, 13C and 31P) and
ESI-MS data.
Compounds 2 and 3 were coupled with phosphoramidites 4 and 5 in the three different prositions
using 0.45 M DCI (Scheme 3).
Scheme 3. Synthesis of Phosphate-Linked Silibinin dimers 6–8, Reagents and conditions: (a) 0.45 M DCI,
DCM, rt (b) 5.5 M TBHP in decane, rt (c) 28% NH4OH aqueous solution and CH3OH (1:1, v:v), 50 ◦C.
After the oxidative treatment with 5.5 M tert-butyl hydroperoxide (TBHP) solution in decane,
the crude material was purified by gel chromatography. Several complex fractions were recovered,
but only those with a 31P-NMR signal were treated with a 28% NH4OH aqueous solution and CH3OH
(1:1, v:v) at 50 ◦C, allowing the full deprotection from isobutyric and cyanoethyl groups. After RP-18
HPLC analyses and purification, the products were converted into the corresponding sodium salts by
cation exchange on a DOWEX (Na+ form) resin, leading to the desired phosphodiester derivatives 6–8
in good yields (17%, 15% and 20%, respectively).
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As expected, the NMR spectra of the new dimers look like those of a mixture of compounds
(a diastereoisomer mixture), so unfortunately a more detailed analysis was not possible. The products
obtained by cation exchange as sodium salts were suspended in DMSO-d6, but the NMR spectra did
not allow a detailed assignment of the different spin systems. Dimers 6–8 were finally characterized by
31P-NMR and MALDI-MS (Table 1).
2.2. Antioxidant Activity: DPPH Test
The DPPH test is a non-enzymatic method commonly used to provide basic information on
the scavenging potential of stable free radicals in vitro. In a preliminary study, the new derivatives
were subjected to a DPPH free radical scavenging assay (Table 1), and for comparison purposes,
the antioxidant activity of silibinin and quercetin were evaluated as controls. In all cases, the radical
scavenging activities of the dimers 6–8 were better than that of silibinin (1).
Table 1. Characterization of the Phosphate-Linked Silibinin dimers 6–8.
Compound MALDI tR (min) a DPPH IC50 (mM) t1/2 (h)
6 Calcd. for C50H43O22P = 1026.20found [M − H]− = 1025.12; [MNa − H]− = 1047.09 13.6 0.58 ± 0.04 86.7
7 Calcd. for C50H43O22P = 1026.20found [M − H]− = 1025.28; [MNa − H]− = 1047.09 13.4 0.55 ± 0.05 85.6
8 Calcd. for C50H43O22P = 1026.20found [M − H]− = 1025.11; [MNa − H]− = 1048.99 14.7 0.34 ± 0.07 81.2
Silibinin (1) – – 1.40 ± 0.06 –
Quercetin – – 0.18 ± 0.01 –
a For analysis conditions see Section 3.8.
2.3. Cytotoxicity (MMT Test) and Protective Activity (X/XO Assay)
The new silibinin dimers 6–8 were non-cytotoxic to HepG2 cells, with cell viabilities exceeding
90% at concentrations that higher than 10 µM (20, 50 and 100 µM) and at 24 h of exposure (Figure 2A).
The new compounds were also non-cytotoxic, with cell viabilities exceeding 90% after 48 h exposure
(data not shown). The antioxidant activity of the dimers 6–8 was evaluated using HepG2 cells as
models and the 2′,7′-dichlorofluorescin diacetate (DCFH-DA) test.
Figure 2. (A) The effects of 24 h treatment on HepG2 cell viability as determined by MTT assay.
Different letters indicate significant differences among control and different concentrations (One way
ANOVA, p < 0.05); (B) Protection against XO-induced intracellular ROS generation: DCF fluorescence
was measured in basal conditions (white bars) or following cells exposure to X/XO system for 3 h
(green bars). The cells were pretreated with each dimer (6–8) at concentrations of 20 µM. The values
are expressed as % compared to the fluorescence value observed in control untreated cells which was
set at 100. Asterisk indicates significant differences between basal conditions and exposure to X/XO,
*: p < 0.05, ***: p < 0.001; different letters indicate significant differences among control, silibinin (1), 6,
7 and 8 within basal conditions and exposure to X/XO (Two way ANOVA).
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In this assay, intracellular reactive oxygen species (ROS) levels were measured by the oxidative
conversion of stable, non-fluorescent DCFH-DA to the highly fluorescent 2′,7′-dichlorofluorescein
(DCF) occurring in the presence of ROS [25,26]. In particular, DCFH-DA easily crosses cell membranes
and is transformed to non-fluorescent DCFH via a hydrolysis reaction catalysed by intracellular
esterases. Reactions between DCFH and intracellular ROS lead to a highly fluorescent product,
dichlorofluorescin, that is detectable with a spectrofluorometer.
Oxidative stress was induced by incubating HepG2 cells with xanthine oxidase (XO), which is the
important biological source of free radicals, and many references reveal cerebral microvascular injury
resulting from the XO production of superoxide free radicals [27–30]. HepG2 cells were incubating with
XO in the presence of its substrate xanthine (X) for a period of 3 h, and the oxidation of non-fluorescent
DCFH-DA to the highly fluorescent DCF was used for the quantitation of intracellular ROS production.
For testing the cytoprotective effects, HepG2 cells were pre-treated for 24 h with the tested compounds
and then treated with XO and its substrate xanthine for periods of 3 h. As shown in Figure 2B,
all dimers were able to slightly reduce the basal endogenous levels of ROS, and they were also able to
scavenge most of the free radicals generated by the X/XO system, showing a higher activity than that
of silibinin.
2.4. Serum Stability
Blood and extracellular fluid contain a large number of hydrolytic enzymes, such as
cholinesterases, aldolases, lipases, dehydropeptidases, and alkaline phosphatases. Several functional
groups, such as ester, amide, carbamate, lactam, lactone, sulphonamide and, of course, phosphate,
are susceptible to plasma degradation. If the new compound has affinity for one of these enzymes and
has a hydrolysable group in the right position, then it can be decomposed in the plasma. Hydrolysis in
plasma can be a major cause of compound clearance, and pharmacologically efficacious concentrations
may not be achievable in vivo in a pre-clinical study. With the presence of a phosphodiester bridge,
which could be susceptible to the action of endogenous phosphatase before the active complex can
reach its molecular target, the stability of the new synthesized conjugates was evaluated in human
serum and was monitored over time by HPLC analysis (Figure 3).
Figure 3. Abundance (%) of the dimers 6–8 treated with human serum at 37 ◦C and analysed by
RP-HPLC (see Section 3.13).
As shown in Figure 3, the abundance of the dimers decreases slowly, recording half-lives of
81–87 h (Table 1).
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2.5. Water Solubility
As reported in the literature, the water solubility of silibinin changes according to the experimental
conditions, such as pH and temperature [8,31]. In this section, we determined the solubility of the new
dimers 6–8 and silibinin (1) in water.
Solubility experiments were performed by dissolving the selected compound in Milli-Q H2O
for 10 min under magnetic stirring in the dark. Molar absorption coefficients (ε) for each compound
in water were determined from calibration curves (absorbance vs. concentration), with successive
dilutions of a stock solution using the Beer-Lamberts law. For silibinin, the stock solution was prepared
in CH3CN (1.18 mg in 1 mL), and absorption spectra were recorded by diluting the silibinin solution
in H2O (2% of CH3CN used to increase the solubility and, as a consequence, quantification limit).
UV-vis spectra are presented in Figure 4, revealing the presence of an absorption band that is centred at
approximately 288 nm, corresponding to the pi–pi* transition, and at approximately 334 nm, which could
be attributed to the transition n–pi* that occurs on the oxygen of ketones groups. The silibinin was only
slightly dissolved when 0.5 mg was suspended in 10 mL of H2O, and after filtration, the absorption
spectrum revealed a maximum at 288 nm with an absorption of ~0.018. The saturated concentration of
silibinin in H2O was estimated to be 0.9 µM, corresponding to ~0.44 mg·L−1 (Table 2). The solution
was also kept in the dark and stirred for 12 h without any significant solubility increase.
Figure 4. UV-Vis spectra of the silibinin in H2O-CH3CN (98:2) solution and the dimers in H2O at pH 6.5.
Table 2. Spectroscopic characteristics and solubility of the silibinin (1) and the dimers (6–8) at pH = 6.5.
Compound ε288nm (M−1·cm−1) Suspended in10 mL
Theoretical
Concentration
Abs288 nm after
Filtration
Solubility in
H2O
1 22,158 (CH3CN)19,469 (H2O/CH3CN, 98:2)
0.44 mg 91.2 µM * 0.018 ≤0.9 µM(0.4 mg·L−1)
6 9100 (H2O) 0.10 mg 19.5 µM 0.18
≥19.5 µM
(20.3 mg·L−1)
7 14,435 (H2O) 0.10 mg 19.5 µM 0.30
≥19.5 µM
(20.3 mg·L−1)
8 18,536 (H2O) 0.10 mg 19.5 µM 0.35
≥19.5 µM
(20.3 mg·L−1)
* The solution was saturated and the suspension was filtered before of the analysis.
To investigate the possible increased solubility at a higher pH, a phosphate buffer solution at pH
8.0 was prepared (buffer concentration of 1 mM), and 0.35 mg of silibinin was suspended in 15 mL.
After 10 min of magnetic stirring followed by filtration through a 0.45-µm filter, the UV-vis spectrum
revealed the presence of two absorption maxima: the first at 288 nm, attributed to the silibinin with an
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absorption of ~0.02 (in agreement with solubility determination at pH 6.5), and the second centred
at approximately 330 nm, indicating the formation of silibinin degradation products in the alkaline
solution. The solubility experiments that are summarized in Table 2 indicate that the dimers were
completely dissolved (0.1 mg in 10 mL) in H2O, and solubility can be estimated to be ≥19.5 µM,
corresponding to >20.3 mg·L−1.
2.6. Reactivity with 1O2 and HO·
The reactivity of the silibinin and the dimers with 1O2 and HO
• is determined using Rose Bengal
(RB) and hydrogen peroxide (H2O2) as respective ROS sources. For singlet oxygen, the steady-state
concentration in the solution [1O2]SS in H2O was determined by following tryptophan disappearance
at different initial concentrations. The kinetic approach is summarized in reactions (R1)–(R3):
RB
O2, hν→ 1O2 Rf1O2(Ms
−1) (R1)
1O2 → 3O2 k1O2(s−1) (R2)
1O2 + TRP→ products k1O2,TRP
(
M−1s−1
)
(R3)
where Rf1O2
being the rate of formation of 1O2 upon irradiation of RB, k1O2 is the pseudo-first decay of
singlet oxygen in H2O (2.4 × 105 s−1), and k1O2,TRP is the second order rate constant between 1O2 and
TRP (3.2 × 107 M−1·s−1). Application of the steady-state approximation to 1O2 leads to the following
equation:
1
RdTRP
=
1
R f1O2
(1+
k1O2
k1O2,TRP[TRP]
) (EQ1)
1
RdTRP
data vs. different TRP concentrations can be fitted with a linear equation, y = ax+ b, leading
to a quantification of the singlet oxygen steady state concentration ([1O2]SS) that is equal to the ratio
R1
f
O2
/k1O2 . The dimer reactivity towards singlet oxygen was similar to the value determined for
silibinin (see dimer 6 or approximately 35% lower in the case of dimer 8—Table 3). The second order
rate constant was on the same order of magnitude as that reported in the literature for molecules
with a similar structure. Morales and co-workers [32] reported a reactivity ranging from 2.4 to
13.4 × 107 M−1·s−1 for flavonoid derivatives such as quercetin and morin.
Table 3. Singlet oxygen steady state concentrations [1O2] and second order rate constant (kI I1O2,X )
between singlet oxygen and silibinin (1) or dimers (6–8) in THF and H2O solutions.
Compound
THF H2O
[1O2]SS (M) k
II
1O2,X (M
−1s−1) [1O2]SS (M) kII1O2,X (M
−1·s−1)
1 3.79 × 10−13 6.1 ± 0.4 × 107 - -
6 - - 4.07 × 10−13 6.8 ± 1.2 × 107
7 - - 4.07 × 10−13 5.4 ± 0.3 × 107
8 - - 4.07 × 10−13 4.0 ± 0.2 × 107
Experimental data such as those reported in Figure 5 for dimers 6 and 7 (Abs/Abs0 followed at
475 nm vs. dimer concentration) are fitted with a linear Equation (EQ1), leading to the estimation of
the second order rate constant between the hydroxyl radical and the selected molecule.
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Figure 5. Abs/Abs0 measured at 475 nm as a function of 6 (PLSd 3-3) and 7 (PLSd 3-9′ ′). The solid line
represents the linear fit of the experimental data, and dashed lines denote the 95% confidence interval
of this fit.
Estimation of the second order rate constant indicates that the most reactive species are dimers
7 and 8, with a second order rate constant ≥ 1.5 × 1010 M−1·s−1 (see Table 4 summarizing the
experimental results). Wang and co-workers [33] investigated the reactivity of the hydroxyl radical
with phenolic compounds to estimate their antioxidative ability using aqueous pulse radiolysis.
A value of 1.5 × 1010 M−1·s−1 was found for quercetin, which is closest to the value estimated for
green tea polyphenols. Interestingly, Husain et al. [34] reported that the reactivity of flavonoids towards
photogenerated hydroxyl radical increases with the number of hydroxyl groups in the aromatic ring.
Table 4. Second order rate constant (kIIHO• ,X) between hydroxyl radical and 1 or dimers 6–8 in
H2O/CH3CN (9:1) solutions.
Compound kIIHO• ,X (M
−1·s−1)
1 8.26 ± 1.64 × 109
6 6.73 ± 0.32 × 109
7 1.52 ± 0.08 × 1010
8 ≥2.0 × 1010
3. Materials and Methods
3.1. General Methods
Reactions for the synthesis of dimers were monitored by thin layer chromatography (TLC)
on precoated silica gel plates F254 (Merck, Darmstadt, Germany) and column chromatography
was performed on Merck Kieselgel 60 (70–230 mesh). For the ESI MS analyses, a Micromass ZQ
Instrument (Waters, Milan, Italy) equipped with an electrospray source was used. MALDI TOF mass
spectrometric analyses were performed on a Voyager-De Pro MALDI mass spectrometer (PerSeptive
Biosystems, Framingham, MA, USA). Absorption spectra were measured with a Cary 100 Scan UV-Vis
spectrophotometer (Varian, Santa Clara, CA, USA) using a 1-cm path length quartz cell.
3.2. Chemicals
Silibinin (purity ≥98% by HPLC) was purchased from Sigma-Aldrich (Milan, Italy). HPLC grade
CH3CN and CH3OH were purchased from Carlo Erba Reagents (Milan, Italy) and Sigma-Aldrich.
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Hydrogen peroxide (H2O2) (30%) was purchased from Fluka (Milan, Italy). Unless otherwise
indicated, all other chemicals were obtained from Sigma Aldrich, and their purity was >98%. Fresh
aqueous solutions of hydrogen peroxide, Rose Bengal and tryptophan were prepared prior to each
experiment. The concentration of the stock solution of H2O2 in Milli-Q H2O (for the laser flash
photolysis experiments) was determined using a molar absorption coefficient of 38.1 ± 1.4 M−1·cm−1
at 240 nm [20].
3.3. Synthesis of Silibinin Building Block 2
Silibinin (1, 1.5 g, 3.1 mmol) previously dried by repeated co-evaporation with anhydrous THF
was dissolved in anhydrous THF (8 mL) and TEA (2.1 mL, 15.4 mmol). Isobutyryl chloride (0.980 mL,
9.3 mmol) was added, and the mixture was kept at 0 ◦C for 30 min. After reaction completion as
monitored by TLC, the reaction was stopped by the addition of CH3OH, and the mixture was extracted
with CH2Cl2. The organic phase was dried over anhydrous Na2SO4 and concentrated under reduced
pressure, and the crude material was purified by column chromatography (CHCl3-acetone, 96:4, v/v).
The derivative 3,5,7,4′ ′-tetra-O-isobutyrylsilibinin (2) was obtained as a pale amorphous solid (0.365 g,
0.47 mmol, 15%). Rf = 0.6 (benzene/EtOAc, 80:20, v/v). 1H-NMR (CDCl3, 400 MHz, room temperature,
mixture of two diastereoisomers): δ = 7.15–6.96 (6H, complex signals, H-2′, H-5′, H-6′, H-2′ ′, H-5′ ′,
H-6′ ′), 6.77 (1H, complex signal, H-8), 6.58 (1H, s, H-6), 5.71 and 5.69 (1H, d, J = 12.2/12.3 Hz, H-3),
5.38 (1H, m, H-2), 5.08 and 5.06 (1H, d, J = 8.3/8.7 Hz, H-7′ ′), 4.04 (1H, m, H-8′ ′), 3.88–3.83 (4H,
overlapped signals, OCH3, H-9′ ′a), 3.58 (1H, dd, J = 3.2 Hz, J = 12.0 Hz, H-9′ ′b), 2.98–2.74 (3H, complex
signals, CH of isobutyryl groups), 2.62–2.52 (1H, m, CH of isobutyryl group), 1.41–1.25 (18H, m, CH3
of isobutyryl groups), 1.15–1.10 (6H, m, CH3 of isobutyryl group) ppm. 13C-NMR (CDCl3, 100 MHz,
room temperature, mixture of diastereoisomers): δ = 185.0, 175.2, 175.1, 175.0, 174.1, 162.5, 162.4, 156.5,
151.7, 151.6, 144.0, 144.1, 143.7, 140.6, 134.5, 128.7, 123.1, 123.0, 121.0, 120.8, 119.8, 119.7, 117.1, 117.0,
116.6, 116.4, 111.2, 111.1, 108.7, 81.1, 81.0, 78.3, 78.4, 76.0, 75.9, 72.9, 72.8, 61.5, 56.1, 56.0, 34.3, 34.0,
33.7, 19.0, 18.8, 18.7, 18.6 ppm. ESI-MS (positive ions): m/z calculated for C41H46O14 = 762.29; found:
763.84 [MH]+.
3.4. Synthesis of Silibinin Building Block 3
Silibinin (1, 1.0 g, 2.7 mmol) previously dried by repeated co-evaporation with anhydrous THF
was dissolved in anhydrous THF (8 mL) and TEA (2.1 mL, 15.4 mmol), and isobutyryl chloride (1.1 mL,
10.4 mmol) was added. The mixture was kept at 0 ◦C for 30 min. After it was monitored by TLC,
the reaction was stopped by the addition of CH3OH, and the mixture was extracted with CH2Cl2;
the organic phase was then dried over anhydrous Na2SO4 and concentrated under reduced pressure.
The crude material was purified by column chromatography (CHCl3-acetone, 96:4, v/v). The derivative
5,7,4′ ′,9′ ′-tetra-O-isobutyrylsilibinin (3) was obtained as a pale amorphous solid (0.447 g, 0.58 mmol,
28%). Rf = 0.9 (benzene/EtOAc, 80:20, v/v). 1H-NMR (CDCl3, 400 MHz, room temperature, mixture of
two diastereoisomers): δ = 7.21–6.98 (complex signals, 6H, H-2′, H-5′, H-6′, H-2′ ′, H-5′ ′, H-6′ ′), 6.76
(1H, complex signal, H-8), 6.59 (1H, s, H-6), 5.07 (1H, d, J = 12.8 Hz, H-2), 5.00 (1H, d, J = 8.3 Hz, H-7′ ′),
4.56 and 4.55 (1H, d, J = 12.3/12.4 Hz, H-3), 4.44 (1H, dd, J = 2.3 Hz, J = 12.9 Hz, H-9′ ′a), 4.26 (1H,
m, H-8′ ′), 3.98 (1H, dd, J = 2.3 Hz, J = 12.8 Hz, H-9′ ′b), 3.86 (3H, s, OCH3), 2.98–2.76 (3H, complex
signals, CH of isobutyryl groups), 2.61 (1H, ept, J = 6.8 Hz, CH of isobutyryl group), 1.36 (18H, complex
signals, CH3 of isobutyryl groups), 1.21 (6H, m, CH3 of isobutyryl group) ppm. 13C-NMR (CDCl3,
100 MHz, room temperature, mixture of two diastereoisomers): δ = 191.2, 176.4, 175.0, 174.9, 174.1,
163.1, 157.0, 151.7, 151.5, 144.0, 143.5, 140.8, 134.3, 129.3, 123.2, 121.4, 121.2, 119.8, 117.5, 117.4, 116.6,
116.5, 111.1, 110.9, 109.7, 108.9, 83.2, 76.2, 75.9, 75.8, 73.1, 73.0, 62.4, 56.0, 34.3, 34.1, 34.0, 33.9, 19.0, 18.9,
18.7, 18.6 ppm. ESI-MS (positive ions): m/z calculated for C41H46O14 = 762.29; found: 763.66 [MH]+.
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3.5. Synthesis of Silibinin Building Block 4
DIEA (390 µL, 2.22 mmol) and 2-cyanoethyl-N,N-diisopropylaminochlorophosphoramidite
(107 µL, 0.48 mmol) were added to 3,5,7,4′ ′-tetra-O-isobutyrylsilibinin (2, 240.0 mg, 0.33 mmol)
dissolved in anhydrous CH2Cl2 (5 mL). After 30 min, the solution was diluted with EtOAc, and
the organic phase was washed twice with brine and then concentrated. Silica gel chromatography of
the residue (n-hexane-EtOAc, 30:70, v/v, in the presence of 1% of Et3N) afforded the desired compound
4 (205.0 mg, 0.24 mmol) with a 65% yield. Rf = 0.8 (n-hexane/EtOAc, 60:40, v/v). 1H-NMR (CDCl3,
500 MHz, room temperature, mixture of four diastereoisomers): δ = 7.11–6.94 (6H, overlapped signals,
H-2′, H-3′, H-6′, H-2′ ′, H-5′ ′, H-6′ ′), 6.76 (1H, complex signals, H-8), 6.56 (1H, s, H-6), 5.69 (×2), 5.68
and 5.67 (1H, d, J = 12.2 Hz, H-3), 5.38, 5.37 (×2) and 5.36 (1H, d, J = 12.2 Hz, H-2); 5.03 (×2) and
5.01 (×2) (1H, d, J = 7.2/7.5 Hz, H-7′ ′), 4.00–3.51 (12H, complex signals, OCH3, H-8′ ′, H-9′ ′a, H-9′ ′b,
OCH2CH2CN, N[CH(CH3)2]2 OCH2CH2CN), 3.01–2.68 (3H, m, CH of isobutyryl groups), 2.56 (1H, m,
CH of isobutyryl group) 1.36–0.95 (36H, complex signals, CH3 of isobutyryl groups, N[CH(CH3)2]2)
ppm. 13C-NMR (CDCl3, 100 MHz, room temperature, mixture of diastereoisomers): δ = 185.0, 175.2,
175.1, 175.0, 174.1, 162.5, 162.4, 156.5, 151.7, 151.5, 144.5, 143.4, 143.3, 140.5, 134.7, 128.3, 128.2, 123.0,
122.9, 121.0, 120.9, 120.8, 119.9, 119.8, 119.7, 117.7, 117.5, 117.1, 116.4, 116.3, 111.5, 111.4, 111.3, 111.1,
111.0, 110.8, 108.7, 81.2, 81.1, 76.2, 75.9, 75.8, 72.9, 72.8, 62.7, 62.5, 62.2, 62.0, 58.8, 58.6, 58.5, 58.3, 56.0,
55.9, 53.4, 43.3, 43.2, 34.2, 34.0, 33.9, 33.6, 24.6, 24.5, 19.0, 18.8, 18.7, 18.6 ppm. 31P-NMR (CDCl3, 161.98
MHz): δ = 150.2, 149.8, 149.7 ppm. ESI-MS (positive ions): m/z calculated for C50H63N2O15P = 962.40;
found: 963.92 [MH]+.
3.6. Synthesis of Silibinin Building Block 5
DIEA (390 µL, 2.22 mmol), and 2-cyanoethyl-N,N-diisopropylaminochlorophosphoramidite
(107 µL, 0.48 mmol) were to 5,7,4′ ′,9′ ′-tetra-O-isobutyrylsilibinin (3, 240.0 mg, 0.33 mmol) dissolved
in anhydrous CH2Cl2 (5 mL). After 1 h, the solution was diluted with EtOAc, and the organic phase
was washed twice with brine and then concentrated. Silica gel chromatography of the residue
(n-hexane-EtOAc, 3:7, v/v, in the presence of 1% of Et3N) afforded the desired compound 5 (205.0 mg,
0.24 mmol) in a 65% yield. Rf = 0.8 (n-hexane/EtOAc, 60:40, v/v). 1H-NMR (CDCl3, 500 MHz, room
temperature, mixture of four diastereoisomers): δ = 7.30–6.97 (6H, overlapped signals, H-2′, H-3′,
H-6′, H-2′ ′, H-5′ ′, H-6′ ′), 6.73 (1H, complex signals, H-8), 6.54 (1H, complex signal, H-6), 5.02 (×2)
and 5.01 (×2) (1H, d, J = 7.8/8.0 Hz, H-7′ ′), 4.94 (1H, d, J = 9.3 Hz, H-2), 4.43 (1H, complex signal,
H-3), 4.34 (complex signal, 1H, H-9′ ′a), 4.20 (1H, complex signal, H-8′ ′), 4.10–3.94 (1H, complex
signals, H-9′ ′b), 3.86 (3H, complex signal, OCH3), 3.54–3.34 (6H, complex signals, OCH2CH2CN,
N[CH(CH3)2]2 OCH2CH2CN) 2.96–2.74 (3H, complex signals, CH of isobutyryl groups), 2.65 (1H,
complex signal, CH of isobutyryl group), 1.40–1.10 (36H, complex signals, CH3 of isobutyryl groups,
N[CH(CH3)2]2) ppm. 13C-NMR (CDCl3, 100 MHz, room temperature, mixture of diastereoisomers):
δ = 189.0, 188.3, 176.4, 176.3, 174.9, 174.2, 174.1, 162.3, 156.3, 156.1, 149.9, 143.9, 143.8, 143.4, 143.3, 140.8,
135.9, 134.2, 129.5, 129.4, 129.3, 123.2, 121.7, 121.6, 119.7, 119.6, 117.8, 117.5, 117, 4, 117.3, 116.8, 116.6,
111.3, 111.1, 111.0, 108.6, 83.1, 82.9, 76.2, 75.8, 75.6, 75.2, 62.4, 62.3, 59.7, 59.5, 58.5, 58.3, 56.0, 43.5, 43.4,
34.2, 34.1, 33.9, 24.8, 24.7, 24.6, 24.2, 24.1, 19.0, 18.9, 18.8, 18.7, 18.6 ppm. 31P-NMR (CDCl3, 161.98
MHz): δ = 153.2, 153.0, 152.3, 152.2 ppm. ESI-MS (positive ions): m/z calculated for C50H63N2O15P =
962.40; found: 963.43 [MH]+.
3.7. Synthesis of Phosphate-Linked Silibinin Dimers 6–8
The coupling reaction between the phosphoramidites 4 or 5 and the suitable silibinin building
block 2 or 3 was carried out by suspending 240 mg (0.32 mmol) of derivative 2 (or 3) in a solution
of 4,5-dicyanoimidazole in acetonitrile (DCI, 0.45 M) and by adding 3-Å molecular sieves. After a
few min, the mixture was added to 270 mg (0.28 mmol) of silibinin phosphoramidite 4 (or 5) and
stirred for 1 h. Upon completion of reaction as monitoed by TLC analysis, tert-butyl hydroperoxide
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(TBHP) solution in decane (150 µL, 5.5 M) was added, and after 30 min, the solvent was removed under
vacuum, and the crude material was purified by column chromatography (eluent CHCl3/CH3OH,
99:1 to 95:5, v/v). The material obtained was subsequently subjected to treatment with a 28% NH4OH
aqueous solution and methanol (1:1, v/v) at 50 ◦C for 3 h for the full deprotection.
Compound 6 (pale yellow, 49 mg, 17%): 31P-NMR (161.98 MHz, DMSO-d6, room temperature, mixture
of diastereoisomers) δ = −1.61. MS (MALDI-TOF) m/z calcd. for C50H43O22P = 1026.20, found 1025.12
[M − H]−, 1047.09 [M + Na − 2H]−.
Compound 7 (pale yellow, 43 mg, 15%): 31P-NMR (161.98 MHz, DMSO-d6, room temperature, mixture
of diastereoisomers) δ = −1.64. MS (MALDI-TOF) m/z calcd. for C50H43O22P = 1026.20, found 1025.28
[M − H]−, 1047.09 [M + Na − 2H]−.
Compound 8 (pale yellow, 58 mg, 20%): 31P-NMR (161.98 MHz, DMSO-d6, room temperature, mixture
of diastereoisomers) δ = −1.62. MS (MALDI-TOF) m/z calcd. for C50H43O22P = 1026.20, found 1025.11
[M − H]−, 1048.99 [M + Na − 2H]−.
3.8. HPLC Analysis and Purification of 6–8
The sample solutions were prepared by dissolving and sonicating the accurately weighed
compound (6–8) in H2O/CH3OH (1:1, v/v). The obtained solution was filtered using nylon filters
(pore size = 0.45 µm) and then purified. The HPLC analysis was performed with an LC-9A
HPLC system (Shimadzu, Milan, Italy) equipped with a Shimadzu SPD-6A detector using a RP18
column (LUNA, Phenomenex, Bologna, Italy, 5 µm particle size, 10.0 mm × 250 mm i.d.) eluted
with ammonium acetate 0.1 M (pH = 7.0) with a linear gradient of 5–100% ACN for 20 min
(flow = 0.8 mL·min−1) and monitored at 288 nm. The preparative HPLC method was performed
with a Shimadzu LC-8A PLC system (Shimadzu, Milan, Italy) equipped with a Shimadzu SCL-10A
VP System control and Shimadzu SPD-10A VP UV-VIS Detector. A Phenomenex Gemini C18-110A
preparative column (5-µm particle size, 250 mm × 21.2 mm i.d.) was eluted with ammonium acetate
0.1 M with a linear gradient of 20–100% ACN for 50 min (flow = 7 mL/min). The chromatograms
were monitored at 288 and 254 nm. The HPLC system was controlled by the Shimadzu LC Real Time
Analysis software (LCsolution Version 1.25, Shimadzu, Milan, Italy). The recovered material was
desalted on a Chromafix® C18 column (Macherey Nagel, Milan, Italy) eluted with H2O/CH3OH (8:2,
v/v) and converted into the corresponding sodium salt by cation exchange on a DOWEX resin (Na+)
column, affording compounds 6–8 in good yields (17%, 15% and 20%, respectively).
3.9. DPPH Test
The free radical scavenging activities of the test compounds at different concentrations were
evaluated by their abilities to quench the stable 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) in vitro.
A DPPH solution (20 mg/mL) was prepared in methanol. The compounds were dissolved in methanol
to prepare the stock solution (1 mM). A freshly prepared DPPH solution was aliquoted into test tubes,
and analogue solutions (1 mM−1 µM) were added to every test tube so that the final volume was
2.25 mL. After 10 min, the absorbance was read at 515 nm. Silibinin and quercetin were used as
reference standards and dissolved in methanol to make a stock solution at the same concentration
(1 mM).
3.10. Evaluation of Cell Viability (MTT Assay)
Cell viability was measured using an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
bromide] assay on HepG2 cells. Cells were plated at a density of 2 × 104 cells·well−1 in 96-well
plates, and after 36 h, the medium was replaced with fresh medium supplemented with the tested
compounds. After 24 h, the cell medium was replaced with 200 µL of MTT solution (5 mg·mL−1
stock solution in PBS) and diluted with culture medium to a final concentration of 0.5 mg·mL−1.
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After a 4 h incubation at 37 ◦C, this solution was removed, and the formazan was solubilized in
100 µL of DMSO. The absorbance was monitored at 572 nm using an automated microplate reader
(PowerWave XS2; BioTek Instruments Inc., Winooski, VT, USA). Cell viabilities were calculated by
comparing the results to those for control cells considered 100% viable. The cells were assayed in
triplicate independent experiments.
3.11. Xanthine/Xanthine Oxidase (X–XO) Assay
Cells (2 × 104 cells) were seeded on 96-well plates. The cells were pretreated with each dimer
(6–8) at concentrations of 20 µM for 24 h and then exposed to X (0.5 mM) and XO (5 mU·mL−1) for
3 h. The cell plates were washed twice with Hanks’ Balanced Salt Solution (HBSS) and incubated
in the same buffer containing 10 µM DCFH-DA for 1 h at 37 ◦C in the dark. Oxidation of the
dye by intra-cellular ROS generates a fluorescent 2′,7′-dichlorofluorescin (DCF) signal. Intracellular
fluorescence was detected using a SPECTRA max GEMINI spectrofluorometer (Molecular Devices,
Rome, Italy, excitation wavelength, 495 nm; emission wavelength, 530 nm).
3.12. Statistical Analysis
Data were collected and are expressed as the mean ± standard deviation of three independent
experiments. Statistical analysis was performed by ANOVA tests. A p < 0.05 was considered significant.
3.13. Serum Stability
Tests were performed in 500 µL of 50 mM Tris·HCl (pH 8.0 containing 10 mM MgCl2), 50 µL of
10 µM solution of 6–8, and human serum from human male AB plasma (400 µL). All reactions were
incubated at 37 ◦C and small aliquots of the mixture were taken at defined time intervals, kept at 85 ◦C
for 5 min, equilibrated at rt, and analysed by RP-HPLC. HPLC analyses were carried out by RP-HPLC
using a Phenomenex Luna C18 column (5 µm particle size, 10.0 mm × 250 mm i.d., Phenomenex,
Bologna, Italy) eluted with 0.1 M ammonium acetate with a linear gradient 20–100% ACN for 30 min
(flow = 1.5 mL·min−1).
3.14. Singlet Oxygen Reactivity
To estimate the reactivity of silibinin and the dimers towards singlet oxygen, solutions were
irradiated in a quartz cell of 1 cm path length using 545 nm centred irradiation (1000 W xenon lamp
equipped with a monochromator) in the presence of 100 µM RB as a photosensitizer for singlet oxygen
generation [35]. An aliquot of the solution was collected at fixed intervals of time and analysed by
liquid chromatography. Figure 6 shows the absorption spectra of RB and the overlap with the emission
spectra reaching the solution, recorded using fibre optics coupled with a CCD spectrophotometer
(USD 2000, UV-vis 200–850 nm, Ocean Optics, Paris, France). A reference lamp (DH-2000-CAL, Ocean
Optics) was used for calibration.
Silibinin was solubilized in THF, whereas the dimers were solubilized in an H2O/CH3CN (9/1,
v/v) mixture. THF and CH3CN were used as solvents to increase the silibinin and dimer solubility
and due to their similar reactivity with singlet oxygen compared to the water (i.e., only limited singlet
oxygen scavenging is accounted for by the solvent) [36]. The degradation of silibinin and the dimer
as determined as follows: an aliquot (200 µL) was taken at fixed interval times during irradiation,
stored in the dark and monitored by ultra-high performance liquid chromatography using a Waters
Acquity UPLC instrument equipped with a diode array detector and a Waters 2695 separation module.
The gradient is as follows: a linear increase from 1% CH3CN and 99% H2O acidified with 0.1% of
formic acid to 50% CH3CN within 5 min. Then, CH3CN was increased linearly to 80% for 2 min and
maintained constant for 2 min. The column was a Water Acquity UPLC C18 (100 mm × 2.1 mm ×
1.7 µm) with a flow rate of 0.3 mL·min-1. The retention times of silibinin and the 3-3, 3-9′ ′ and 9′ ′-9′ ′
dimers were 5.4, 6.3, 7.0 and 7.3 min, respectively, with the detection wavelength set at 288 nm.
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The time evolution of silibinin and dimers in the presence of singlet oxygen could be fitted with a
pseudo-first order equation Ct = C0 exp
−k1O2 t where C0 is the initial concentration of compound, Ct the
concentration at time t and k1O2 the pseudo-first order degradation rate constant of target compound
(X). The degradation rate (RdX) was determined as R
d
X = k1O2 C0.
Singlet oxygen steady-state concentration [1O2]SS using 100 µM RB under irradiation is quantified
under experimental conditions using tryptophan as probe. The transformation rate of silibinin or
dimers in the presence of singlet oxygen is given by the following relation: RdX = k
I I
1O2,X
[1O2]SS[X]
where [X] is the concentration of silibinin or dimers in solution. The second order rate constant between
target molecule and singlet oxygen (kI I1O2,X(M
−1·s−1)) can be determined as: kI I1O2,X =
RdX
[1O2]SS[X]
. Singlet
oxygen steady-state concentration [1O2]SS is quantified with tryptophan as probe using experimental
conditions adopted for silibinin and dimmers considering a second order rate constant between TRP
and 1O2 of 3.2 × 107 M−1·s−1 [37].
Figure 6. Emission spectrum reaching the solution (1000 W xenon lamp equipped with
a monochromator) and absorption spectrum of a 10 µM RB solution.
3.15. Hydroxyl Radical (HO•) Generation and Reactivity Estimation
Due to the high reactivity of THF with hydroxyl radical (~4.0 × 109 M−1·s−1) [38], stock solutions
of H2O2, thiocyanate (SCN−), silibinin and the dimers were prepared in Milli-Q H2O or CH3CN
(for silibinin), and an appropriate volume was mixed just before each experiment to obtain the
desired concentration. Experiments in pure H2O were performed for the dimers, whereas for silibinin,
a CH3CN/H2O (9:1) solution was used. All experiments were performed at ambient temperature
(295 ± 2 K) and in an aerated solution.
Hydroxyl radicals were generated from 266 nm excitation of the H2O2 solution, corresponding
to the fourth harmonic of a GCR 130-01 Nd:YAG laser system instrument (Quanta Ray) used in a
right-angle geometry with respect to the monitoring light beam. The single pulse was 9 ns in duration,
and the energy was 40 mJ. Individual cuvette samples (~3 mL volume) were used for a maximum of
two consecutive laser shots to avoid degradation product formation and interference. The transient
absorbance at the pre-selected wavelength was followed by a detection system consisting of a pulsed
xenon lamp (150 W), a monochromator and a photomultiplier (1P28). A spectrometer control unit
was used to synchronise the pulsed light source and programmable shutters with the laser output.
The signal from the photomultiplier was digitised by a programmable digital oscilloscope (HP54522A)
and analysed using a 32 bit RISC-processor kinetic spectrometer workstation.
The UV-vis spectrum of HO• presents a maximum that is centred at 240 nm, and direct
quantification was difficult due to the low molar absorption coefficient (ε240nm) of ~600 M−1·cm−1 [39].
For this reason, a kinetic approach based on SCN− competition reactivity is generally adopted to
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estimate the second order rate constant of target compounds with HO• in solution based on the
following equations:
H2O2
LFP 266nm→ 2HO• (R4)
HO• + SCN− → HO−+ SCN• (R5)
HO• + X→ products (R6)
SCN•+ SCN− → SCN•−2 (R7)
The first step (R4) was hydrogen peroxide photolysis using a laser pulse at 266 nm followed by
competition reactivity of the generated HO•with SCN− (R5) and silibinin (or dimers) (R6). In the
presence of a high concentration of SCN−, thiocyanate radical (SCN•) reacts with another equivalent
of thiocyanate to form a di-thiocyanate radical anion (SCN•−2 ) (R7), which has a strong absorption
molar coefficient at 475 nm (ε475nm = 7600 M−1·cm−1) [40].
The absorption of SCN•−2 in the presence of different concentrations of HO
• quenchers (X) allows
for the determination of the second-order rate constant between hydroxyl radicals and silibinin or the
dimers using the following equation:
Abs0
Abs
= 1+
kI IHO• ,X[X]
kI I
HO• ,SCN− [SCN
−]
(E1)
where Abs0 and Abs are the transient absorption of SCN•−2 at 475 nm, respectively, with and without
quencher; kI IHO• ,SCN− is the second-order rate constant between HO
• and thiocyanate, which is
1.2 × 1010 M−1·s−1 [41]; [SCN−] is the initial concentration of thiocyanate (0.1 or 0.5 mM in our
study); [X] is the concentration of target compound; and kI IHO• ,X is the second order rate constant with
the hydroxyl radical. Abs0Abs values vs. the concentration of quencher ([SY]) can be fitted using a linear
equation, y = ax + b, in which y = Abs0Abs , b = 1, x = [X], and a =
kI IHO• ,X
kI I
HO• ,SCN− [SCN
− ] . The k
I I
HO• ,X value can
be determined to be equal to a × kI IHO• ,SCN− [SCN−]. Stock solutions of H2O2, SCN−, silibinin and the
dimers were prepared in Milli-Q H2O or CH3CN (for silibinin), and an appropriate volume was mixed
just before each experiment to obtain the desired concentration of all the species. Experiments in pure
H2O were performed for the dimers, whereas for silibinin, 10% CH3CN in a H2O solution was used.
All experiments were performed at ambient temperature (295 ± 2 K) and in aerated solutions.
4. Conclusions
New promising synthetic metabolites 6–8 named Phosphate-Linked Silibinin dimers were
synthesized in very good yields, using an efficient synthetic strategy exploiting the well-known
phosphoramidite chemistry. Their antioxidant properties were evaluated by different approaches
(DPPH test, X/XO system, ROS reactivity). Knowing the strong limitations of silibinin, mainly due to
its poor bioavailability, the water solubility of the new derivatives was evaluated. The new dimers
(PLSd) presented a good water solubility (more than 20 mg·L−1) under circumneutral pH values,
whereas the silibinin was found to be poorly soluble (less than 0.4 mg·L−1). In a preliminary study
the antioxidant activities of the PLSd were evaluated by DPPH free radical scavenging test showing a
pronounced increase of the activity for the dimers in comparison to the silibinin. The PLSd showed a
very low toxicity towards HepG2 cells (even for long exposure times) and a half-life time in human
serum of approximately three days at 37 ◦C. The cytoprotective activity of the PLSd was evaluated
on HepG2 cells using the DCF assay where the oxidative stress tests were carried out using the
xanthine/xanthine oxidase system. All the dimers showed a strong ability to scavenge most of the free
radicals generated by X/XO on HepG2 cells and in all cases more efficiently than silibinin. Moreover,
the anti-oxidant activities of the new derivatives were further investigated towards two different ROS,
1O2 and HO•, respectively produced by Rose Bengal and hydrogen peroxide sources. The ability
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to scavenge 1O2 in H2O was tested and despite a similar reactivity for both dimers and silibinin,
indeed a higher reactivity towards HO• (about two times) was estimated for the dimers 7 and 8
respect to the silibinin. Therefore, the second order rate constant for the dimers 7 and 8 is major than
1.5 × 1010 M−1·s−1 value very similar to that reported for a known potent antioxidant as quercetin.
The combination of the great antioxidant ability with low toxicity as well as their serum stability,
makes the PLSd promising synthetic metabolites in the large class of polyphenols.
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